ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

Biotechnology

Healthcare
$7.65 -0.75%

-$0.07 today

Market cap
$795.08M
Beta
1.06
P/E (TTM)
-6.7
EPS (TTM)
-$1.28
52W Low $7.23High $14.93

Volume 1.39M

Average 1.91M

ORIC EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How ORIC compares with its peers on the latest reported figures

ORIC Competitors Peer median
EBITDA Margin for ORIC and competitors
Company Period LTM level YoY 3-year change
MGNXMacroGenics, Inc.LTM Mar 2026-32.2% -1.2 pp+32.0 pp
NUVBNuvation Bio Inc.LTM Jun 2026-74.8% +1326.6 pp—
SNDXSyndax Pharmaceuticals, Inc.LTM Mar 2026-74.8% +669.1 pp—
VSTMVerastem, Inc.LTM Mar 2026-387.1% +1063.3 pp+2084.9 pp
JANXJanux Therapeutics, Inc.LTM Mar 2026-520.3% +290.5 pp-393.5 pp
ORICORIC Pharmaceuticals, Inc.FY2025— ——
ELVNEnliven Therapeutics, Inc.FY2025— ——
TYRATyra Biosciences, Inc.FY2025— ——
CRVSCorvus Pharmaceuticals, Inc.FY2025— ——
NVCTNuvectis Pharma, Inc.FY2025— ——
AVBPArriVent BioPharma, Inc. Common StockFY2025— ——
Peer median (excluding ORIC) -74.8%+669.1 pp+32.0 pp

Competitors are the stored peer set for ORIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue001.03M1.11M1.22M
Gross Profit00(1.03M)(1.11M)(1.22M)
Gross Margin—————
Research & Development56.86M61.68M85.17M114.07M109.82M
Selling, General & Admin22.01M25.09M25.61M28.82M33.19M
Operating Expenses78.87M91.77M109.75M141.79M141.78M
Depreciation & Amortization897K966K1.03M1.11M1.22M
EBITDA(77.82M)(85.8M)(99.67M)(126.74M)(128.25M)
EBITDA Margin—————
Operating Income(78.87M)(91.77M)(110.78M)(142.9M)(143M)
Operating Margin—————
Interest Income141K2.65M10.08M00
Interest Expense02.65M000
Other Income / Expenses156K2.65M10.08M15.05M13.54M
Income Before Tax(78.72M)(89.12M)(100.7M)(127.85M)(129.47M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(78.72M)(89.12M)(100.7M)(127.85M)(129.47M)
Net Margin—————
EPS (Basic)(2.07)(2.25)(1.96)(1.83)(1.47)
EPS (Diluted)(2.07)(2.25)(1.96)(1.83)(1.47)
Weighted Avg Shares37.95M39.66M51.45M69.73M87.79M
Weighted Avg Shares (Diluted)37.95M39.66M51.45M69.73M87.79M

ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

Intrinsic Alpha fair value

Locked

Current Price

$7.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.